Bart N.
- Country
- Belgium
- Department
- Medical Oncology
Research Overview
- Evaluation of RO7276389 Monotherapy and Combination with Cobimetinib in BRAF-V600 Mutation-Positive Advanced Solid Tumors or Melanoma with CNS Metastases
- Evaluation of CVGBM Vaccine Efficacy and Safety in Patients with Surgically Resected Glioblastoma or Astrocytoma with Unmethylated Glioblastoma Signature
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
Data & Insights
Has run more than one trial at 105 of 304 partner sites.
Specializations
Melanoma Research
The investigator specializes in studying various therapeutic approaches for advanced and metastatic melanoma, with particular focus on immunotherapy treatments. Their research encompasses both early-stage and late-stage melanoma, including cases with specific genetic mutations.
- Advanced melanoma treatment strategies
- NRAS mutant cutaneous melanoma
- BRAF-V600 mutation-positive melanoma
- Neoadjuvant therapy approaches
Brain Cancer Studies
The investigator conducts research in glioblastoma treatment, focusing on innovative therapeutic approaches for both newly diagnosed and recurrent cases. Their work includes investigation of combination immunotherapy strategies and novel treatment delivery methods.
- Recurrent glioblastoma management
- Intracranial treatment administration
- Post-surgical therapeutic interventions
Advanced Tumor Therapies
The investigator explores treatments for various advanced tumors, with emphasis on immunological approaches and targeted therapies. Their research includes evaluation of novel therapeutic combinations and treatment strategies for complex cases.
- Solid tumor interventions
- Combination therapy approaches
- Advanced malignancy management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.